CPH Group AG, formerly CPH Chemie + Papier Holding AG, operates as a Switzerland-based industrial group focused on specialty chemicals and pharmaceutical packaging solutions. The company develops, manufactures and distributes molecular sieves, special zeolites, chromatography gels and deuterated solvents through its Chemistry division under the Zeochem brand; it provides PVC mono films and coated PVdC barrier films for pharmaceutical blister packaging under the Perlen Packaging brand. Founded in 1818 and headquartered in Perlen, Switzerland, CPH Group maintains production facilities in Switzerland, Germany, Bosnia and Herzegovina, Hungary, Israel, the USA, Brazil, China and India, serving customers primarily in Europe, Asia and North and South America across pharmaceutical, chemical and related industries.
In a major strategic restructuring completed in 2024, the company spun off its Paper division, encompassing newsprint and magazine paper production along with associated real estate, into a separate entity named Perlen Industrieholding AG, enabling CPH Group AG to concentrate on its growth-oriented Chemistry and Packaging segments. Recent acquisitions include the successful closing of LOG Pharma by Perlen Packaging in early 2025 to bolster pharmaceutical packaging capabilities and the acquisition of substantial assets from SiliCycle Inc., a Canadian firm specializing in silica-based products, by Zeochem in July 2025. Additionally, Dr. Alois Waldburg-Zeil assumed the role of CEO in February 2025, succeeding the prior executive after 16 years, amid ongoing efforts to expand international presence and achieve stable earnings growth.